Clinical Pharmacokinetics and Pharmacological Effects of Carbamazepine and Carbamazepine-10,11-Epoxide
暂无分享,去创建一个
[1] R. Ramsay,et al. Drug‐induced downbeat nystagmus , 1982, Annals of neurology.
[2] E. Perucca,et al. Diurnal Fluctuations in Free and Total Steady‐State Plasma Levels of Carbamazepine and Correlation with Intermittent Side Effects , 1984, Epilepsia.
[3] P. Lascelles,et al. ALTERED RATIO OF CARBAMAZEPINE‐10,11‐EPOXIDE/CARBAMAZEPINE IN PLASMA OF CHILDREN: EVIDENCE OF ANTICONVULSANT DRUG INTERACTION , 1984, Developmental medicine and child neurology.
[4] J. Mackichan. Simultaneous liquid chromatographic analysis for carbamazepine and carbamazepine 10,11-epoxide in plasma and saliva by use of double internal standardization. , 1980, Journal of chromatography.
[5] P. Joensen,et al. Clonazepam (Rivotril®) and Carbamazepine (Tegretol®) in Psychomotor Epilepsy: A Randomized Multicenter Trial , 1981, Epilepsia.
[6] T. Tomson,et al. VALPROMIDE/CARBAMAZEPINE AND RISK OF TERATOGENICITY , 1985, The Lancet.
[7] B. Wilder,et al. A double‐blind study comparing carbamazepine with phenytoin as initial seizure therapy in adults , 1983, Neurology.
[8] E. Perucca,et al. Reversal by phenytoin of carbamazepine-induced water intoxication: a pharmacokinetic interaction. , 1980, Journal of neurology, neurosurgery, and psychiatry.
[9] L. Bertilsson. Clinical Pharmacokinetics of Carbamazepine , 1978, Clinical pharmacokinetics.
[10] A. Richens,et al. SERUM-PHENYTOIN LEVELS IN MANAGEMENT OF EPILEPSY , 1975, The Lancet.
[11] L. Bertilsson,et al. Autoinduction of carbamazepine metabolism in children examined by a stable isotope technique , 1980, Clinical pharmacology and therapeutics.
[12] L. Malinen,et al. A double‐blind comparison of carbamazepine and clomethiazole in the treatment of alcohol withdrawal syndrome , 1981, Acta psychiatrica Scandinavica.
[13] D. Scheffner,et al. A Comparative Controlled Study Between Carbamazepine and Diphenylhydantoin in Psychomotor Epilepsy , 1976, Epilepsia.
[14] S. Garattini,et al. Pharmacokinetic Studies on Carbamazepine in Volunteers and in Epileptic Patients , 1975 .
[15] S. Pynnönen,et al. CARBAMAZEPINE AND MOTHER'S MILK , 1975, The Lancet.
[16] G. L. Cooper,et al. Carbamazepine intoxication caused by interaction with isoniazid. , 1982, British medical journal.
[17] G. Solomon,et al. CARBAMAZEPINE IN DIFFICULT TO CONTROL EPILEPTIC OUT‐PATIENTS , 1975, Acta neurologica Scandinavica. Supplementum.
[18] C. Binnie,et al. POSSIBLE HAZARD OF VALPROMIDE-CARBAMAZEPINE COMBINATION THERAPY IN EPILEPSY , 1984, The Lancet.
[19] C. Bowden,et al. Effects of carbamazepine on plasma haloperidol levels. , 1985, Journal of clinical psychopharmacology.
[20] M. Eadie,et al. Factors Influencing Simultaneous Concentrations of Carbamazepine and Its Epoxide in Plasma , 1981, Therapeutic drug monitoring.
[21] J. Hulsman,et al. Correlation Between Daily Fluctuations of Carbamazepine Serum Levels and Intermittent Side Effects , 1980, Epilepsia.
[22] O. Munck,et al. Antiepileptic Drugs: Metabolism in Pregnancy , 1979, Clinical pharmacokinetics.
[23] W. Rapeport,et al. Carbamazepine 10, 11 epoxide concentrations in epileptics on carbamazepine alone and in combination with other anticonvulsants. , 1983, British journal of clinical pharmacology.
[24] B. Höjer,et al. Kinetics of carbamazepine and its 10,11‐epoxide metabolite in children , 1976, Clinical pharmacology and therapeutics.
[25] R. Belmaker,et al. Carbamazepine and haloperidol v placebo and haloperidol in excited psychoses. A controlled study. , 1984, Archives of general psychiatry.
[26] J. Bruni,et al. Effects of carbamazepine and its epoxide metabolite on amygdala‐kindled seizures in rats , 1984, Neurology.
[27] T. Sato,et al. The levels of anticonvulsants in breast milk. , 1979, British journal of clinical pharmacology.
[28] Neuvonen Pj. Bioavailability and central side effects of different carbamazepine tablets. , 1985 .
[29] H. Kutt. Interactions Between Anticonvulsants and Other Commonly Prescribed Drugs , 1984, Epilepsia.
[30] M. Eadie,et al. Simultaneous Plasma Carbamazepine and Carbamazepine‐Epoxide Concentrations in Pharmacokinetic and Bioavailability Studies , 1985, Therapeutic Drug Monitoring.
[31] R. Belmaker,et al. Carbamazepine-induced reduction of blood levels of haloperidol in chronic schizophrenia , 1985, Biological Psychiatry.
[32] G. Avanzini,et al. Plasma Concentrations of Carbamazepine and Carbamazepine 10,11-Epoxide During Pregnancy and After Delivery , 1985, Clinical pharmacokinetics.
[33] P. Neuvonen,et al. Interaction between Doxycycline and some Antiepileptic Drugs , 1974, British medical journal.
[34] T. Tomson. Interdosage fluctuations in plasma carbamazepine concentration determine intermittent side effects. , 1984, Archives of neurology.
[35] S. Pynnönen,et al. Carbamazepine: placental transport, tissue concentrations in foetus and newborn, and level in milk. , 2009, Acta pharmacologica et toxicologica.
[36] E. Perucca. Free Level Monitoring of Antiepileptic Drugs Clinical Usefulness and Case Studies , 1984, Clinical pharmacokinetics.
[37] S. Johannessen,et al. CSF concentrations and serum protein binding of carbamazepine and carbamazepine-10,11-epoxide in epileptic patients. , 1976, British journal of clinical pharmacology.
[38] J. Aicardi,et al. Pharmacokinetics of carbamazepine in the neonate and in the child. , 1979, International journal of clinical pharmacology and biopharmacy.
[39] Francesco Monaco,et al. Carbamazepine‐10,11‐Epoxide Determined by EMIT Carbamazepine Reagent , 1980, Epilepsia.
[40] D. Schmidt,et al. Utility of Free Level Monitoring of Antiepileptic Drugs , 1985, Epilepsia.
[41] S. Johannessen,et al. Single‐Drug Therapy with Carbamazepine in Patients with Epilepsy: Serum Levels and Clinical Effect , 1980, Epilepsia.
[42] V. P. Sweeney,et al. Isoniazid-induced carbamazepine toxicity and vice versa: a double drug interaction. , 1982, The New England journal of medicine.
[43] P. Lascelles,et al. CORRELATION BETWEEN PLASMA CARBAMAZEPINE‐10,11‐EPOXIDE CONCENTRATION AND DRUG SIDE‐EFFECTS IN CHILDREN WITH EPILEPSY , 1984, Developmental medicine and child neurology.
[44] L. Bertilsson,et al. Determination of carbamazepine and its epoxide metabolite in plasma by high-speed liquid chromatography. , 1975, Journal of chromatography.
[45] M. Levine,et al. Differential effect of cimetidine on serum concentrations of carbamazepine and phenytoin , 1985, Neurology.
[46] E. Perucca,et al. Effect of Dose Increments on Serum Carbamazepine Concentration in Epileptic Patients , 1980, Clinical pharmacokinetics.
[47] T. Tomson,et al. Potent therapeutic effect of carbamazepine-10,11-epoxide in trigeminal neuralgia. , 1984, Archives of neurology.
[48] J. Sonne,et al. Lack of interaction between cimetidine and carbamazepine , 1983, Acta neurologica Scandinavica.
[49] C. Gardner-Thorpe. Antiepileptic drug monitoring , 1977 .
[50] M. Eichelbaum,et al. Carbamazepine Levels in Breast Milk , 1984, Therapeutic drug monitoring.
[51] M. Cohen,et al. Salivary concentrations and plasma protein binding of carbamazepine and carbamazepine 10,11-epoxide in epileptic patients. , 1981, British journal of clinical pharmacology.
[52] B. Bourgeois,et al. Carbamazepine‐10,11‐diol Steady‐State Serum Levels and Renal Excretion During Carbamazepine Therapy in Adults and Children , 1984, Therapeutic drug monitoring.
[53] H. Nau,et al. Anticonvulsants during Pregnancy and Lactation Transplacental, Maternal and Neonatal Pharmacokinetics , 1982, Clinical pharmacokinetics.
[54] A. Rane,et al. Formation of carbamazepine epoxide in human fetal liver. , 1978, Drug metabolism and disposition: the biological fate of chemicals.
[55] M. Dam,et al. INTERACTION OF PROPOXYPHENE WITH CARBAMAZEPINE , 1977, The Lancet.
[56] T. Okuno,et al. Carbamazepine as a sole anticonvulsant for partial seizures , 1979, Brain and Development.
[57] P. Loiseau,et al. Carbamazepine/Valproic Acid Interaction in Man and Rhesus Monkey , 1984, Epilepsia.
[58] M. Eadie,et al. Preliminary observations on the clinical pharmacology of carbamazepine ('Tegretol'). , 1974, Proceedings of the Australian Association of Neurologists.
[59] T. Tomson,et al. Carbamazepine Metabolism in Man , 1985, Clinical pharmacokinetics.
[60] A. Baruzzi,et al. Carbamazepine and carbamazepine-10, 11-epoxide concentrations in human brain. , 1977, British journal of clinical pharmacology.
[61] M. Dam,et al. INFLUENCE OF PHENOBARBITAL AND DIPHENYLHYDANTOIN ON PLASMA CARBAMAZEPINE LEVELS IN PATIENTS WITH EPILEPSY , 1973, Acta neurologica Scandinavica.
[62] L. Skovsted,et al. Carbamazepine‐induced acceleration of diphenylhydantoin and warfarin metabolism in man , 1971, Clinical pharmacology and therapeutics.
[63] J. J. Zielinski,et al. Carbamazepine‐Phenytoin Interaction: Elevation of Plasma Phenytoin Concentrations Due to Carbamazepine Comedication , 1985, Therapeutic drug monitoring.
[64] A. Kumps. Dose-dependency of the ratio between carbamazepine serum level and dosage in patients with epilepsy. , 1981, Therapeutic drug monitoring.
[65] H. Lüders,et al. High‐dose monotherapy in treatment of intractable seizures , 1984, Neurology.
[66] D. Schmidt,et al. Therapeutic plasma levels of phenytoin, phenobarbital, and carbamazepine , 1984, Neurology.
[67] M. Aman,et al. Fluctuations in Salivary Carbamazepine and Carbamazepine‐10,11‐Epoxide Concentrations During the Day in Epileptic Children , 1983, Epilepsia.
[68] H. Nau,et al. Carbamazepine and carbamazepine-10,11- epoxide during pregnancy and postnatal period in epileptic mother and their nursed infants: pharmacokinetics and clinical effects. , 1983, Pediatric pharmacology.
[69] T. Tomson,et al. Pharmacokinetics: Time‐Dependent Changes— Autoinduction of Carbamazepine Epoxidation , 1986, Journal of clinical pharmacology.
[70] A. Kumps. Simultaneous HPLC determination of oxcarbazepine, carbamazepine and their metabolites in serum , 1984 .
[71] M. Horning,et al. Metabolism of carbamazepine. , 1982, Drug metabolism and disposition: the biological fate of chemicals.
[72] T. Tomson,et al. Single‐dose kinetics and metabolism of carbamazepine‐10,11‐epoxide , 1983, Clinical pharmacology and therapeutics.
[73] M. Sillanpää,et al. Carbamazepine in the Treatment of Partial Epileptic Seizures in Infants and Young Children: A Preliminary Study , 1979, Epilepsia.
[74] T. Tomson,et al. Trigeminal Neuralgia: Time Course of Pain in Relation to Carbamazepine Dosing , 1981, Cephalalgia : an international journal of headache.
[75] T. Tomson,et al. Carbamazepine therapy in trigeminal neuralgia: clinical effects in relation to plasma concentration. , 1980, Archives of neurology.
[76] J. Cramer,et al. Interaction between valproic acid and carbamazepine: an in vitro study of protein binding. , 1982, Therapeutic drug monitoring.
[77] B. Wannamaker,et al. Kinetics of a carbamazepine‐ethosuximide interaction , 1980, Clinical pharmacology and therapeutics.
[78] B. Bourgeois,et al. Individual and combined antiepileptic and neurotoxic activity of carbamazepine and carbamazepine-10,11-epoxide in mice. , 1984, The Journal of pharmacology and experimental therapeutics.
[79] K. Otani. Risk Factors for the Increased Seizure Frequency during Pregnancy and Puerperium , 1985, Folia psychiatrica et neurologica japonica.
[80] L. Bertilsson,et al. Metabolism of carbamazepine and its epoxide metabolite in human and rat liver in vitro. , 1981, Drug metabolism and disposition: the biological fate of chemicals.
[81] C. Dravet,et al. Carbamazepine Intoxication Due to Triacetyloleandomycin Administration in Epileptic Patients , 1980, Epilepsia.
[82] R. Levy. Metabolism of antiepileptic drugs , 1984 .
[83] J. Cate,et al. Carbamazepine‐Erythromycin Interaction Leading to Carbamazepine Toxicity in Four Epileptic Children , 1983, Therapeutic drug monitoring.
[84] R. Post,et al. The efficacy of carbamazepine in affective illness. , 1984, Advances in biochemical psychopharmacology.
[85] R. Cutler,et al. Time‐course of interaction between carbamazepine and clonazepam in normal man , 1978, Clinical pharmacology and therapeutics.
[86] J. Modell,et al. Inpatient clinical trial of lorazepam for the management of manic agitation. , 1985, Journal of clinical psychopharmacology.
[87] M. Eichelbaum,et al. Kinetics and metabolism of carbamazepine during combined antiepileptic drug therapy , 1979, Clinical pharmacology and therapeutics.
[88] D. Lindhout,et al. Teratogenicity of Antiepileptic Drug Combinations with Special Emphasis on Epoxidation (of Carbamazepine) , 1984, Epilepsia.
[89] E. Perucca. Pharmacokinetic Interactions with Antiepileptic Drugs , 1982, Clinical pharmacokinetics.
[90] C. Dodrill,et al. Carbamazepine—A double‐blind comparison with phenytoin , 1977, Neurology.
[91] R. Kenny,et al. A prospective study between carbamazepine, phenytoin and sodium valproate as monotherapy in previously untreated and recently diagnosed patients with epilepsy. , 1985, Journal of neurology, neurosurgery, and psychiatry.
[92] H. Begleiter,et al. Brain stem auditory evoked potentials in unmedicated schizophrenic patients , 1985, Biological Psychiatry.
[93] H. Glatt,et al. Epoxides metabolically produced from some known carcinogens and from some clinically used drugs. I. Differences in mutagenicity , 1975, International journal of cancer.
[94] D. Janz. Epilepsy, pregnancy, and the child , 1982 .
[95] N. Callaghan,et al. Carbamazepine as a single drug in the treatment of epilepsy. A prospective study of serum levels and seizure control. , 1978, Journal of neurology, neurosurgery, and psychiatry.
[96] E. Usdin. Frontiers in Biochemical and Pharmacological Research in Depression , 1984, Psychological Medicine.
[97] Yerby Ms,et al. Carbamazepine protein binding and disposition in pregnancy. , 1985 .
[98] R. Post,et al. Carbamazepine and its -10,11-epoxide metabolite in plasma and CSF. Relationship to antidepressant response. , 1983, Archives of general psychiatry.
[99] A. Richens,et al. Antiepileptic therapy : advances in drug monitoring , 1980 .
[100] M. Friis,et al. Carbamazepine, carbamazepine‐10,11‐epoxide and phenytoin concentrations in brain tissue of epileptic children , 1978, Acta neurologica Scandinavica.